MedPath

Study changes in LIPID PROFILE and ANTHROPOMETRIC measures on METABOLIC SYNDROME patients after giving flaxseed powder and also study the MOLECULAR PARAMETERS against normal healthy human.

Not Applicable
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Registration Number
CTRI/2020/07/026318
Lead Sponsor
self sponsored
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects between the ages of 20-75 years.

No regular history of sunflower seed intake, fish intake, and soy intake; flaxseed or flaxseed oil supplement or fish oil supplement intake.

The subject voluntarily agrees to participate by providing written informed consent.

The subject agrees to provide permission to obtain all medical records necessary for complete data ascertainment during the follow-up period.

Exclusion Criteria

Subject has a history of type 1 diabetes mellitus or a history of ketoacidosis

Subject who donâ??t come under at least 3 criteria of MetS.

Patients having a history of cardiac disease, kidney, liver-related diseases.

Regular history of sunflower seed, fish intakes, and flaxseed oil supplement or fish oil supplement intake.

Evidence of significant active neuropsychiatric disease.

The subject has taken/is currently taking any herbals, dietary supplements, or medications, other than oral hypoglycemic medications, during the past four weeks prior to screening visit that could profoundly affect blood glucose.

The subject is known to be allergic or intolerant to any ingredient found in the study products.

Avoid the use of flaxseed and flaxseed oil during pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Flaxseed powder and lifestyle modification will improve lipid profile. the relationship with MTHFR and galectin 3 will be associated this other risk in metabolic syndromeTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Association and correlation of MTHFR gene and galectin -3 marker between metabolic syndrome Vs Diabetes, hypertension, and cardiovascular disease ( lipid abnormalities) will be evaluated to test for independent association.Timepoint: Approx 6 months . 5 month for Flaxseed powder supplementation.
© Copyright 2025. All Rights Reserved by MedPath